Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study

被引:304
作者
McKone, EF
Emerson, SS
Edwards, KL
Aitken, ML
机构
[1] Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98195 USA
[2] Univ Washington, Adult Cyst Fibrosis Ctr, Seattle, WA 98195 USA
[3] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[4] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
关键词
D O I
10.1016/S0140-6736(03)13368-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Over 1000 mutations of the cystic fibrosis transmembrane conductance regulator gene (CFTR) that cause cystic fibrosis have been identified. We examined the effect of CFTR genotype on mortality and disease phenotype. Methods Using the US Cystic Fibrosis Foundation National Registry, we did a retrospective cohort study to compare standardised mortality rates for the 11 most common genotypes heterozygous for DeltaF508 with those homozygous for DeltaF508. Of the 28455 patients enrolled in the registry at the time of our analysis, :17 853 (63%) were genotyped. We also compared the clinical phenotype, including lung function, age at diagnosis, and nutritional measures, of 22 DeltaF508 heterozygous genotypes. Mortality rates and clinical phenotype were also compared between genotypes classified into six classes on the basis of their functional effect on CFTR production. Findings Between 1991 and 1999, genetic and clinical data were available for 17 853 patients with cystic fibrosis, which was 63% of the total cohort. There were :1547 deaths during the 9 years of follow-up. In the analysis of the 11 most common genotypes, DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/3849+10 kbC-->T, and DeltaF508/2789+5G-->A had a significantly lower mortality rate (4.7, 8.0, 11.9, and 4.4, respectively) than the genotype homozygous for DeltaF508 (21.8, p=0.0060). DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/ 3849+10 kbC-->T, DeltaF508/2789+5G-->A, and DeltaF508/A455E have a milder clinical phenotype. Outcomes for all functional classes were compared with that of class II (containing DeltaF508 homozygotes) and classes IV and V had a significantly lower mortality rate and milder clinical phenotype. Interpretation Patients with cystic fibrosis have distinct genetic subgroups that are associated with mild clinical manifestations and low mortality. These differences in phenotype are also related to the functional classification of CFTR genotype.
引用
收藏
页码:1671 / 1676
页数:6
相关论文
共 33 条
[1]   Seeking modifier genes in cystic fibrosis [J].
Accurso, FJ ;
Sontag, MK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (03) :289-290
[2]  
[Anonymous], CYSTIC FIBROSIS MUTA
[3]  
Cystic Fibrosis Foundation Patient Registry, 2000, 1999 ANN DAT REP
[4]   Modifier genes and variation in cystic fibrosis [J].
Drumm, ML .
RESPIRATORY RESEARCH, 2001, 2 (03) :125-128
[5]   THE CHANGING EPIDEMIOLOGY OF CYSTIC-FIBROSIS [J].
FITZSIMMONS, SC .
JOURNAL OF PEDIATRICS, 1993, 122 (01) :1-9
[6]   A CYSTIC-FIBROSIS MUTATION ASSOCIATED WITH MILD LUNG-DISEASE [J].
GAN, KH ;
VEEZE, HJ ;
VANDENOUWELAND, AMW ;
HALLEY, DJJ ;
SCHEFFER, H ;
VANDERHOUT, A ;
OVERBEEK, SE ;
DEJONGSTE, JC ;
BAKKER, W ;
HEIJERMAN, HGM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (02) :95-99
[7]  
HAMOSH A, 1993, NEW ENGL J MED, V329, P1308
[8]  
Highsmith WE, 1997, HUM MUTAT, V9, P332, DOI 10.1002/(SICI)1098-1004(1997)9:4<332::AID-HUMU5>3.0.CO
[9]  
2-7
[10]   A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS [J].
HIGHSMITH, WE ;
BURCH, LH ;
ZHOU, ZQ ;
OLSEN, JC ;
BOAT, TE ;
SPOCK, A ;
GORVOY, JD ;
QUITTELL, L ;
FRIEDMAN, KJ ;
SILVERMAN, LM ;
BOUCHER, RC ;
KNOWLES, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (15) :974-980